Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase.

Neuroendocrine tumors (NET) often harbor loss-of-function mutations in the MEN1 and DAXX tumor suppressor genes. Here, we report that the products of these genes, menin and Daxx, interact directly with each other to suppress the proliferation of NET cells, to a large degree by inhibiting expression of the membrane metallo-endopeptidase ...
(MME). Menin and Daxx were required to enhance histone H3 lysine9 trimethylation (H3K9me3) at the MME promoter, as mediated partly by the histone H3 methyltransferase SUV39H1. Notably, the menin T429K mutation associated with a NET syndrome reduced Daxx binding, MME repression, and proliferation of NET cells. Conversely, inhibition of MME in NET cells repressed proliferation and tumor growth in vivo Our findings reveal a previously unappreciated cross-talk between two crucial tumor suppressor genes thought to work by independent pathways, focusing on MME as a common target of menin/Daxx to treat NET. Cancer Res; 77(2); 401-11. ©2016 AACR.
Mesh Terms:
Adaptor Proteins, Signal Transducing, Animals, Blotting, Western, Epigenesis, Genetic, Gene Expression Regulation, Neoplastic, Gene Knockdown Techniques, Heterografts, Humans, Immunoprecipitation, Mice, Mice, Nude, Neprilysin, Neuroendocrine Tumors, Nuclear Proteins, Oligonucleotide Array Sequence Analysis, Proto-Oncogene Proteins, Real-Time Polymerase Chain Reaction
Cancer Res.
Date: Dec. 15, 2016
Download Curated Data For This Publication
211322
Switch View:
  • Interactions 6